Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Dri Healthcare Trust DHTRF


Primary Symbol: T.DHT.UN

Healthcare Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:DHT.UN)

DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints

Canada NewsWire 1 day ago

DRI Healthcare Trust Announces Appointment of Annalisa King to Board of Trustees and as Chair of the Audit Committee

Canada NewsWire 5 days ago

DRI Healthcare Trust Announces Voting Results of AGM

Canada NewsWire May 13, 2025

DRI Healthcare Trust Reports First Quarter 2025 Results and Announces Internalization of Manager

Canada NewsWire May 12, 2025

DRI Healthcare Trust to Host First Quarter 2025 Earnings Call and Webcast on May 13, 2025

Canada NewsWire April 22, 2025

Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday

Canada NewsWire March 5, 2025

DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results

Canada NewsWire March 3, 2025

DRI Healthcare Trust to Host Fourth Quarter and Full Year 2024 Earnings Call and Webcast on March 4, 2025

Canada NewsWire January 29, 2025

DRI Healthcare Trust Declares Special Unit Distribution

Canada NewsWire December 20, 2024
View More News ››

Opinion & Analysis (TSX:DHT.UN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:DHT.UN)

RE:RE:RE:RE:NCIB off to a roaring start

The FDA has not requested additional data or studies and has not raised any concerns regarding the safety, efficacy or approvability of...
prophetoffactz - 1 day ago

RE:RE:RE:NCIB off to a roaring start

KALV approval delayed for perhaps 4 weeks.  Cool cool. https://ir.kalvista.com/news-releases/news-release-details/kalvista...
SONOFFERGUS - 1 day ago

RE:RE:RE:RE:RE:NCIB off to a roaring start

Thanks for your response. I follow many Canadian companies with substantial US operations, that flow cash up for Cdn dividend investors....
HermannHaller - 4 days ago

RE:RE:RE:RE:NCIB off to a roaring start

Not yet. The proposed law hits the usual income types under tax treaties -- interest, dividends, rent, royalties -- and would impose US...
SONOFFERGUS - 4 days ago

RE:RE:RE:NCIB off to a roaring start

Have you asked DHT about the section 899 proposal? It's not well defined at this point, but my understanding is that it applies to...
HermannHaller - 5 days ago

RE:RE:NCIB off to a roaring start

Agreed.  The 17th is a big day.  KALV share price sez the FDA approval is happening -- chunking up every day on big volume...
SONOFFERGUS - 5 days ago
View more Bullboard ››

Alphamin Resources Corp.

Alphamin Resources Corp.

Alphamin Resources Corp. is a Mauritius-based company, which is engaged in the production and sale of tin concentrate from ...
View More »